Cargando…
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of p...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690587/ https://www.ncbi.nlm.nih.gov/pubmed/38045693 http://dx.doi.org/10.3389/fimmu.2023.1275828 |
_version_ | 1785152552612921344 |
---|---|
author | Nowotny, Hanna F. Marchant Seiter, Thomas Ju, Jing Gottschlich, Adrian Schneider, Holger Zopp, Stephanie Vogel, Frederick Tschaidse, Lea Auer, Matthias K. Lottspeich, Christian Kobold, Sebastian Rothenfusser, Simon Beuschlein, Felix Reincke, Martin Braun, Leah Reisch, Nicole |
author_facet | Nowotny, Hanna F. Marchant Seiter, Thomas Ju, Jing Gottschlich, Adrian Schneider, Holger Zopp, Stephanie Vogel, Frederick Tschaidse, Lea Auer, Matthias K. Lottspeich, Christian Kobold, Sebastian Rothenfusser, Simon Beuschlein, Felix Reincke, Martin Braun, Leah Reisch, Nicole |
author_sort | Nowotny, Hanna F. |
collection | PubMed |
description | INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of patients with different types of PAI has not been systematically explored, we set out to immunophenotype PAI patients with different causes of glucocorticoid (GC) deficiency. METHODS: This cross-sectional single center study includes 28 patients with congenital adrenal hyperplasia (CAH), 27 after bilateral adrenalectomy due to Cushing’s syndrome (BADx), 21 with Addison’s disease (AD) and 52 healthy controls. All patients with PAI were on a stable GC replacement regimen with a median dose of 25 mg hydrocortisone per day. Peripheral blood mononuclear cells were isolated from heparinized blood samples. Immune cell subsets were analyzed using multicolor flow cytometry after four-hour stimulation with phorbol myristate acetate and ionomycin. Natural killer (NK-) cell cytotoxicity and clock gene expression were investigated. RESULTS: The percentage of T helper cell subsets was downregulated in AD patients (Th1 p = 0.0024, Th2 p = 0.0157, Th17 p < 0.0001) compared to controls. Cytotoxic T cell subsets were reduced in AD (Tc1 p = 0.0075, Tc2 p = 0.0154) and CAH patients (Tc1 p = 0.0055, Tc2 p = 0.0012) compared to controls. NKCC was reduced in all subsets of PAI patients, with smallest changes in CAH. Degranulation marker CD107a expression was upregulated in BADx and AD, not in CAH patients compared to controls (BADx p < 0.0001; AD p = 0.0002). In contrast to NK cell activating receptors, NK cell inhibiting receptor CD94 was upregulated in BADx and AD, but not in CAH patients (p < 0.0001). Although modulation in clock gene expression could be confirmed in our patient subgroups, major interindividual-intergroup dissimilarities were not detected. DISCUSSION: In patients with different etiologies of PAI, distinct differences in T and NK cell-phenotypes became apparent despite the use of same GC preparation and dose. Our results highlight unsuspected differences in immune cell composition and function in PAI patients of different causes and suggest disease-specific alterations that might necessitate disease-specific treatment. |
format | Online Article Text |
id | pubmed-10690587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106905872023-12-02 Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology Nowotny, Hanna F. Marchant Seiter, Thomas Ju, Jing Gottschlich, Adrian Schneider, Holger Zopp, Stephanie Vogel, Frederick Tschaidse, Lea Auer, Matthias K. Lottspeich, Christian Kobold, Sebastian Rothenfusser, Simon Beuschlein, Felix Reincke, Martin Braun, Leah Reisch, Nicole Front Immunol Immunology INTRODUCTION: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of patients with different types of PAI has not been systematically explored, we set out to immunophenotype PAI patients with different causes of glucocorticoid (GC) deficiency. METHODS: This cross-sectional single center study includes 28 patients with congenital adrenal hyperplasia (CAH), 27 after bilateral adrenalectomy due to Cushing’s syndrome (BADx), 21 with Addison’s disease (AD) and 52 healthy controls. All patients with PAI were on a stable GC replacement regimen with a median dose of 25 mg hydrocortisone per day. Peripheral blood mononuclear cells were isolated from heparinized blood samples. Immune cell subsets were analyzed using multicolor flow cytometry after four-hour stimulation with phorbol myristate acetate and ionomycin. Natural killer (NK-) cell cytotoxicity and clock gene expression were investigated. RESULTS: The percentage of T helper cell subsets was downregulated in AD patients (Th1 p = 0.0024, Th2 p = 0.0157, Th17 p < 0.0001) compared to controls. Cytotoxic T cell subsets were reduced in AD (Tc1 p = 0.0075, Tc2 p = 0.0154) and CAH patients (Tc1 p = 0.0055, Tc2 p = 0.0012) compared to controls. NKCC was reduced in all subsets of PAI patients, with smallest changes in CAH. Degranulation marker CD107a expression was upregulated in BADx and AD, not in CAH patients compared to controls (BADx p < 0.0001; AD p = 0.0002). In contrast to NK cell activating receptors, NK cell inhibiting receptor CD94 was upregulated in BADx and AD, but not in CAH patients (p < 0.0001). Although modulation in clock gene expression could be confirmed in our patient subgroups, major interindividual-intergroup dissimilarities were not detected. DISCUSSION: In patients with different etiologies of PAI, distinct differences in T and NK cell-phenotypes became apparent despite the use of same GC preparation and dose. Our results highlight unsuspected differences in immune cell composition and function in PAI patients of different causes and suggest disease-specific alterations that might necessitate disease-specific treatment. Frontiers Media S.A. 2023-11-15 /pmc/articles/PMC10690587/ /pubmed/38045693 http://dx.doi.org/10.3389/fimmu.2023.1275828 Text en Copyright © 2023 Nowotny, Marchant Seiter, Ju, Gottschlich, Schneider, Zopp, Vogel, Tschaidse, Auer, Lottspeich, Kobold, Rothenfusser, Beuschlein, Reincke, Braun and Reisch https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Nowotny, Hanna F. Marchant Seiter, Thomas Ju, Jing Gottschlich, Adrian Schneider, Holger Zopp, Stephanie Vogel, Frederick Tschaidse, Lea Auer, Matthias K. Lottspeich, Christian Kobold, Sebastian Rothenfusser, Simon Beuschlein, Felix Reincke, Martin Braun, Leah Reisch, Nicole Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title | Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title_full | Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title_fullStr | Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title_full_unstemmed | Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title_short | Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
title_sort | major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690587/ https://www.ncbi.nlm.nih.gov/pubmed/38045693 http://dx.doi.org/10.3389/fimmu.2023.1275828 |
work_keys_str_mv | AT nowotnyhannaf majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT marchantseiterthomas majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT jujing majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT gottschlichadrian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT schneiderholger majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT zoppstephanie majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT vogelfrederick majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT tschaidselea majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT auermatthiask majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT lottspeichchristian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT koboldsebastian majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT rothenfussersimon majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT beuschleinfelix majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT reinckemartin majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT braunleah majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology AT reischnicole majorimmunophenotypicabnormalitiesinpatientswithprimaryadrenalinsufficiencyofdifferentetiology |